369 related articles for article (PubMed ID: 12349937)
1. Experimental and theoretical determination of dosimetric characteristics of IsoAid ADVANTAGE 125I brachytherapy source.
Meigooni AS; Hayes JL; Zhang H; Sowards K
Med Phys; 2002 Sep; 29(9):2152-8. PubMed ID: 12349937
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric characteristics of the Pharma Seed model BT-125-I source.
Popescu CC; Wise J; Sowards K; Meigooni AS; Ibbott GS
Med Phys; 2000 Sep; 27(9):2174-81. PubMed ID: 11011748
[TBL] [Abstract][Full Text] [Related]
3. Theoretical and experimental determination of dosimetric characteristics for ADVANTAGE Pd-103 brachytherapy source.
Meigooni AS; Dini SA; Awan SB; Dou K; Koona RA
Appl Radiat Isot; 2006 Aug; 64(8):881-7. PubMed ID: 16713277
[TBL] [Abstract][Full Text] [Related]
4. Experimental determination of dosimetric characteristics of Best 125I brachytherapy source.
Meigooni AS; Gearheart DM; Sowards K
Med Phys; 2000 Sep; 27(9):2168-73. PubMed ID: 11011747
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric characteristics of the InterSource103 palladium brachytherapy source.
Meigooni AS; Sowards K; Soldano M
Med Phys; 2000 May; 27(5):1093-100. PubMed ID: 10841414
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric characteristics of the bests double-wall 103Pd brachytherapy source.
Meigooni AS; Bharucha Z; Yoe-Sein M; Sowards K
Med Phys; 2001 Dec; 28(12):2568-75. PubMed ID: 11797962
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric characteristics of a new 125I brachytherapy source.
Gearheart DM; Drogin A; Sowards K; Meigooni AS; Ibbott GS
Med Phys; 2000 Oct; 27(10):2278-85. PubMed ID: 11099194
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric characteristics of the new RadioCoil 103Pd wire line source for use in permanent brachytherapy implants.
Meigooni AS; Zhang H; Clark JR; Rachabatthula V; Koona RA
Med Phys; 2004 Nov; 31(11):3095-105. PubMed ID: 15587663
[TBL] [Abstract][Full Text] [Related]
9. Monte Carlo dosimetric characterization of the IsoAid ADVANTAGE 103Pd brachytherapy source.
Sowards KT
J Appl Clin Med Phys; 2007 Mar; 8(2):18-25. PubMed ID: 17592461
[TBL] [Abstract][Full Text] [Related]
10. Monte Carlo and thermoluminescence dosimetry of the new IsoSeed model I25.S17 125I interstitial brachytherapy seed.
Lymperopoulou G; Papagiannis P; Sakelliou L; Karaiskos P; Sandilos P; Przykutta A; Baltas D
Med Phys; 2005 Nov; 32(11):3313-7. PubMed ID: 16370418
[TBL] [Abstract][Full Text] [Related]
11. Monte Carlo calculations and experimental measurements of the TG-43U1-recommended dosimetric parameters of 125I (Model IR-Seed2) brachytherapy source.
Sheikholeslami S; Nedaie HA; Sadeghi M; Pourbeigy H; Shahzadi S; Zehtabian M; Hasani M; Meigooni AS
J Appl Clin Med Phys; 2016 Jul; 17(4):430-441. PubMed ID: 27455485
[TBL] [Abstract][Full Text] [Related]
12. Theoretical and experimental determination of dosimetric characteristics for brachyseed Pd-103, model Pd-1, source.
Meigooni AS; Zhang H; Perry C; Dini SA; Koona RA
Appl Radiat Isot; 2003 May; 58(5):533-41. PubMed ID: 12735969
[TBL] [Abstract][Full Text] [Related]
13. Monte carlo investigation of the dosimetric properties of the new 103Pd BrachySeedPd-103 Model Pd-1 source.
Chan GH; Prestwich WV
Med Phys; 2002 Sep; 29(9):1984-90. PubMed ID: 12349919
[TBL] [Abstract][Full Text] [Related]
14. The use of new GAFCHROMIC EBT film for 125I seed dosimetry in Solid Water phantom.
Chiu-Tsao ST; Medich D; Munro J
Med Phys; 2008 Aug; 35(8):3787-99. PubMed ID: 18777938
[TBL] [Abstract][Full Text] [Related]
15. Experimental measurements and Monte Carlo calculations of dosimetric parameters of the IRA1-103Pd brachytherapy source.
Sadeghi M; Hosseini SH; Raisali G
Appl Radiat Isot; 2008 Oct; 66(10):1431-7. PubMed ID: 18387806
[TBL] [Abstract][Full Text] [Related]
16. Experimental determination of the TG-43 dosimetric characteristics of EchoSeed model 6733 I25I brachytherapy source.
Meigooni AS; Dini SA; Sowards K; Hayes JL; Al-Otoom A
Med Phys; 2002 Jun; 29(6):939-42. PubMed ID: 12094988
[TBL] [Abstract][Full Text] [Related]
17. Near-field dosimetry of 125I sources for interstitial brachytherapy implants measured using thermoluminescent sheets.
Iwata K; Yue NJ; Nath R
Med Phys; 2004 Dec; 31(12):3406-16. PubMed ID: 15651623
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism.
Ho Than MT; Munro Iii JJ; Medich DC
J Appl Clin Med Phys; 2015 May; 16(3):5270. PubMed ID: 26103489
[TBL] [Abstract][Full Text] [Related]
19. Study of the IsoAid ADVANTAGE (125)I brachytherapy source dosimetric parameters using Monte Carlo simulation.
Sadeghi M; Hamed Hosseini S
Appl Radiat Isot; 2010 Jan; 68(1):211-3. PubMed ID: 19762248
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric properties of the new 125I BrachySeed model LS-1 source.
Chan GH; Prestwich WV
Med Phys; 2002 Feb; 29(2):190-200. PubMed ID: 11865990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]